House Concurrent Resolution No. by Representative Turner calls on the United States Congress to take action to address the negative impacts of pharmacy benefit managers (PBMs) on the citizens of Louisiana. PBMs, which manage prescription drug benefits for health insurers and government programs, have been criticized for contributing to rising drug costs, lack of pricing transparency, and restrictive formularies that limit patient access to necessary medications. The resolution highlights the disproportionate effects of these practices on vulnerable populations, including seniors and low-income families, and emphasizes the state's commitment to improving access to affordable healthcare.

The resolution urges Congress to implement measures that would increase transparency in PBM operations, ensure that savings from negotiated drug prices are passed on to consumers, regulate anti-competitive practices, enhance oversight of PBM activities, and hold PBMs accountable for any harm caused to patients. It calls for Louisiana's congressional delegation to advocate for reforms that protect the interests of the state's residents and contribute to national healthcare policy improvements. A copy of the resolution will be sent to relevant congressional leaders and Louisiana's congressional delegation.